Quantum Genomics : FRESH impetus in the offing
>FRESH results to be published at the AHA on 7 November - 7 November will be an important date in Quantum Genomics’ story. The French biotech will publish the results of its first phase III trial, FRESH, at the American Heart Association (AHA) Scientific Sessions in Chicago. FRESH aims to show a reduction in systolic blood pressure after 84 days of administering firibastat in patients with resistant hypertension. This first large-scale demonstration stage (n greater ...Quantum Gernomics is a biotechnology firm specializing in the development of innovative drugs to combat cardiovascular diseases. Run by professionals in creating and managing technological start-ups and drug development, as well as researchers and inventors, Co. has established contractual relations with institutions of academic excellence in France (Inserm, CollA
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.